Zentech

History

Over the years, ZenTech has undergone progress and changes that have led it to become a recognized company for these screening solutions around the world.

ZenTech came from one of the first spin-offs from Liège, Techland, a company primarily dedicated to developing tests in the field of endocrinology. In 1988, Techland became the branch of the Italian company RADIM and will be recognized as a research and production center for this company specialized in In Vitro Diagnosis (IVD) and more specifically in RIA (Radio Isotopic Assays). To respond to rapid growth, new production infrastructure was built.

the dates

2001

The year 2001 marked a turning point in the company’s life: The management of RADIM Belgium carried out a Management Buy Out (MBO). ZenTech was created and the company became 100% Belgian.

2006

In 2006, ZenTech acquired the Belgian diagnostics company Gamma and opened the door to a potential new market that would become its priority: neonatal screening.

2009

ZenTech is directing its R&D activities towards the screening of newborn congenital diseases and, in 2009, launched a first solution that integrates reagents on an automatic device. Success will be met first in Southeast Asia, then in multiple countries of Latin America.

In order to complement its portfolio, ZenTech implemented a partnership strategy in the field of newborn screening automation with well-known companies in their field. These partnerships enabled ZenTech to offer a wide range of validated instruments with ZenTech kits today that meet the needs of all sizes of newborn screening laboratories.

2018

In 2018, ZenTech sold its historic portfolio, the RIA portfolio, to fully focus its activities and innovation on neonatal screening.

logo Zentech